Nordic Biotech Advisors ApS

Private limited companyCVR 26123925HellerupActive

Nordic Biotech Advisors ApS is a private limited company, based in Hellerup, active in other activities auxiliary to financial services, except insurance and pension funding, founded in 2001. After a loss in 2024, the company made a profit of DKK 360k in 2025. 8 other companies in the database are registered at the same address.

Follow
PDF reportCompare

Key figures · financial year 2025

Gross profitDKK 3.3m+74.6% vs. 2024
Net profitDKK 360k+162.9% vs. 2024
EquityDKK 4.6m+8.5% vs. 2024
Employees2latest month from CVR

What has changed

calculated from recorded figures and dates

Financials: 2025 against 2024

  • Gross profit rose 75% (2024 → 2025), to DKK 3.3m.
  • Net profit went from a loss of DKK 573k to a profit of DKK 360k (2024 → 2025).
  • Equity rose 8% (2024 → 2025), to DKK 4.6m.

Management and owners, last 24 months

  • Stepped down: Matthew Daniel Perry (board member, 30/06/2026).

Registrations, last 24 months

  • 01/01/2025: Industry changed to Other activities auxiliary to financial services, except insurance and pension funding (661900)

Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.

Financial statements

Financial years 2020–2025 · amounts in DKK thousand

Equity and net profit

−DKK 1mDKK 0DKK 1mDKK 2mDKK 3mDKK 4mDKK 5m202020212022202320242025
EquityNet profit
Financial figures for Nordic Biotech Advisors ApS
202020212022202320242025Change
Revenuenot statednot statednot statednot statednot statednot stated–
Gross profit2,7303,7003,8124,4961,8753,273+74.6%
Operating profit (EBIT)−3419671,2701,809−792637+180.4%
Profit before tax−3879371,2401,832−734512+169.8%
Net profit−3016579431,433−573360+162.9%
Total assets2,5313,2414,2615,2555,3405,382+0.8%
Equity1,8022,4593,4024,8344,2624,622+8.5%
Liabilities7297828594201,078760−29.5%
Cash and cash equivalents1,2452,0392,8093,0223,5041,135−67.6%
Average number of employees–222220%

Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report. Revenue is not stated for 2020, 2021, 2022, 2023, 2024, 2025: smaller companies may omit it, and we do not derive it from other figures.

Download the figures as CSV · free with an account, amounts in whole DKK

DKK 0DKK 1mDKK 2mDKK 3mDKK 4m202020212022202320242025
Gross profitMedian, the industry (136 companies)

Annual reports

6 financial years
Annual reports for Nordic Biotech Advisors ApS
Financial yearPeriodPublishedFigures forDocuments
202501/01/2025 – 31/12/202530/06/2026The companyPDF not statedXBRL
202401/01/2024 – 31/12/202428/06/2025The companyPDFXBRL
202301/01/2023 – 31/12/202319/06/2024The companyPDFXBRL
202201/01/2022 – 31/12/202230/06/2023The companyPDFXBRL
202101/01/2021 – 31/12/202101/07/2022The companyPDFXBRL
202001/01/2020 – 31/12/202011/06/2021The companyPDFXBRL

The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.

Employees

monthly figures from CVR
011223309/2310/2311/2312/2301/2402/2403/2404/2405/2406/2407/2408/2409/2410/2411/2412/2401/2502/2503/2504/2505/2506/2507/2508/2509/2510/2511/2512/2501/2602/2603/2604/2605/2606/2607/2608/26
Employees

Position in the industry

136 companies in the database

Comparison with the other companies in other activities auxiliary to financial services, except insurance and pension funding based on the latest financial year.

Gross profitDKK 3.3mNo. 66 of 133
Better than 51% of the companies in the industry
EquityDKK 4.6mNo. 55 of 136
Better than 60% of the companies in the industry
Number of employees2No. 86 of 136
Better than 37% of the companies in the industry

Industry median: gross profit DKK 3.2m, net profit DKK 326k, equity DKK 2.7m, 4 employees.

DKK 100kDKK 1.2mDKK 14.3mDKK 171.8mDKK 899.6mHere
Distribution of gross profit for 113 companies in the industry (latest financial year, logarithmic scale). Amber bar: where this company sits.

Compared with similar companies

size, age and company form
Rank among similar companies
GroupGross profitEquity
Companies with fewer than 20 employees69,967 companies in the comparison
No. 20,893of 69,742
Better than 70%
No. 14,905of 69,964
Better than 79%
Same industry and fewer than 20 employees112 companies in the comparison
No. 44of 111
Better than 61%
No. 37of 112
Better than 68%
Companies that are between 15 and 29 years old24,910 companies in the comparison
No. 12,432of 24,791
Better than 50%
No. 10,121of 24,909
Better than 59%
All companies of type ApS66,508 companies in the comparison
No. 20,747of 66,379
Better than 69%
No. 11,903of 66,505
Better than 82%

The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.

Compare with the industry

Other activities auxiliary to financial services, except insurance and pension funding
Gross profit
  1. Nordic Biotech Advisors ApSDKK 3.3m
  2. BEC Financial Technologies a.m.b.a.DKK 2.1bn
  3. Mastercard Payment Services Denmark A/SDKK 609.7m
Net profit
  1. Nordic Biotech Advisors ApSDKK 360k
  2. BEC Financial Technologies a.m.b.a.DKK 39.7m
  3. Mastercard Payment Services Denmark A/SDKK 747m
Equity
  1. Nordic Biotech Advisors ApSDKK 4.6m
  2. BEC Financial Technologies a.m.b.a.DKK 1.4bn
  3. Mastercard Payment Services Denmark A/SDKK 1.5bn

Latest financial year per company. Choose up to three companies from the largest in the industry.

Owners and group

from the Public Ownership Register
Owners
  • C. Hansen Invest ApS25%
  • Tech Growth Invest ApS33.33%
  • BVF/Nexgen Biotech, LP25%
Nordic Biotech Advisors ApS

Management

3 active registrations

Executive management

Executive management at Nordic Biotech Advisors ApS
NameRoleAppointed
Florian SchønhartingCEO29/10/2010

Board of directors

Board of directors at Nordic Biotech Advisors ApS
NameRoleAppointed
Florian SchønhartingBoard member29/06/2001
Jakob Mosegaard LarsenBoard member05/12/2011
Founders
Tech Growth Invest ApS, Ckh Invest ApS
Former management (7)
Former management at Nordic Biotech Advisors ApS
NameRoleAppointedResigned
Christian Karsten HansenBoard member29/06/200124/11/2011
Christian Karsten HansenDirector29/06/200124/11/2011
Lars Henrik MunchBoard member29/06/200131/12/2003
Cora Louise MadsenChief financial officer29/06/200116/05/2008
Erik HoffmeyerChair of the board29/06/200131/12/2003
Matthew Daniel PerryBoard member21/01/200230/06/2026
Jennifer Louise PrenderChief financial officer01/03/200829/04/2011

Signing rule: Selskabet tegnes af en direktør i forening med et bestyrelsesmedlem eller af den samlede bestyrelse.

Address and production units

1 active production units

Strandvejen 125
2900 Hellerup

København Municipality · Postcode 2900

Other companies at the address (8)

Production units
Production unitAddressEmployeesP number
NORDIC BIOTECH ADVISORS ApSStrandvejen 125, 2900 Hellerup21008538499

Purpose

Selskabets formål er at virke som finansierings- og investeringsvirksomhed samt anden i forbindelse hermed beslægtet virksomhed.

The purpose is quoted from the register in Danish.

Changes year by year

35 registered events
20262 changesmanagement 1 · accounts 1
  • Matthew Daniel Perry stepped down as board member
  • Annual report for 2025 published
20252 changesaccounts 1 · industry 1
  • Annual report for 2024 published
  • Industry changed to Other activities auxiliary to financial services, except insurance and pension funding (661900)
20241 changeaccounts 1
  • Annual report for 2023 published
20232 changesaddress 1 · accounts 1
  • Moved to Strandvejen 125, 2900 Hellerup
  • Annual report for 2022 published
20221 changeaccounts 1
  • Annual report for 2021 published
20211 changeaccounts 1
  • Annual report for 2020 published
20114 changesmanagement 4
  • Jakob Mosegaard Larsen appointed board member
  • Christian Karsten Hansen stepped down as board member
  • Christian Karsten Hansen stepped down as director
  • Jennifer Louise Prender stepped down as chief financial officer
20102 changesmanagement 1 · address 1
  • Florian Schønharting appointed ceo
  • Moved to Østergade 24A, 1. tv, 1100 København K
20083 changesmanagement 2 · industry 1
  • Cora Louise Madsen stepped down as chief financial officer
  • Jennifer Louise Prender appointed chief financial officer
  • Industry changed to Other activities auxiliary to financial services, except insurance and pension funding (661900)
20071 changeindustry 1
  • Industry changed to Anden servicevirksomhed i forbindelse med pengeinstitutter og finansieringsvirksomhed (671300)
20032 changesmanagement 2
  • Erik Hoffmeyer stepped down as chair of the board
  • Lars Henrik Munch stepped down as board member
20023 changesname 1 · address 1 · management 1
  • Name changed from NEXGEN BIOTECH ApS to NORDIC BIOTECH ADVISORS ApS
  • Moved to Østergade 5, 3, 1100 København K
  • Matthew Daniel Perry appointed board member
200111 changesownership 3 · name 1 · founded 1 · management 6
  • TECH GROWTH INVEST ApS registered as owner (33.33%)
  • BVF/Nexgen Biotech, LP registered as owner (25%)
  • C. HANSEN INVEST ApS registered as owner (25%)
  • Name changed from NORDIC BIOTECH ApS to NEXGEN BIOTECH ApS
  • Registered as NORDIC BIOTECH ApS
  • Erik Hoffmeyer appointed chair of the board
  • Christian Karsten Hansen appointed board member
  • Cora Louise Madsen appointed chief financial officer
  • Florian Schønharting appointed board member
  • Lars Henrik Munch appointed board member
  • Christian Karsten Hansen appointed director

Related companies

Same people in management

Source and updates

The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026.

View in CVRReport a correction